SearchDictionaryMobileLogin

15- hydroperoxy- 5,8,11,13- eicosatetraenoic acid

7  relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: RN given refers to cpd without isomeric designation; (S-(E,Z,Z,Z))-isomer caused dose-dependent constriction of cat coronary arteries; structure in first source

Also Known As:
14,15-epoxyarachidonic acid; 15-HPAA; 15-HPEA; 15-HPETE; 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (E,Z,Z,Z)-isomer; 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (S)-(E,Z,Z,Z)-isomer; 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (Z,Z,Z,Z)-isomer; 15-hydroperoxy-5,8,11,14-eicosatetraenoic acid; 15-hydroperoxyarachidonic acid; arachidonic acid 15-hydroperoxide; 5,8,11,13-eicosatetraenoic acid, 15-hydroperoxy-

Bio-Agent Context: Research Results

Related Diseases

1. Hyperalgesia
2. Thrombosis (Thrombus)
3. Adhesions
4. Atherosclerosis (Atheroma)
5. Hypocapnia

Related Drugs and Biologics

1. Xanthine
2. Xanthine Oxidase
3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4. Oxygen
5. Free Radicals
6. Fatty Acids (Saturated Fatty Acids)
7. Aspirin (Acetylsalicylic Acid)
8. Adenosine Diphosphate (ADP)
9. dazoxiben
10. 15-hydroxy-5,8,11,13-eicosatetraenoic acid

Best Treatments:
Research Summary Report
on Hyperalgesia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic chart